Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Scheipner

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2023
Characteristics of incidental prostate cancer in the United StatesLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|August 15, 2024
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER RegistriesCristina Cano Garcia, Francesco Barletta, Stefano Tappero, et al.
Clinical Genitourinary Cancer|November 19, 2023
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma PatientsLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Urologic Oncology|March 7, 2023
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder CancerStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Surgical Oncology|February 15, 2024
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched studyCarolin Siech, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|December 11, 2024
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care TherapyCarolin Siech, Simone Morra, Lukas Scheipner, et al.
International Urology and Nephrology|August 11, 2024
Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controlsLetizia Maria Ippolita Jannello, Andrea Baudo, Lukas Scheipner, et al.
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of the National Comprehensive Cancer Network : JNCCN|June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active TreatmentReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2023
Characteristics of incidental prostate cancer in the United StatesLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|August 15, 2024
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER RegistriesCristina Cano Garcia, Francesco Barletta, Stefano Tappero, et al.
Clinical Genitourinary Cancer|November 19, 2023
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma PatientsLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Urologic Oncology|March 7, 2023
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder CancerStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Surgical Oncology|February 15, 2024
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched studyCarolin Siech, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|December 11, 2024
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care TherapyCarolin Siech, Simone Morra, Lukas Scheipner, et al.
International Urology and Nephrology|August 11, 2024
Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controlsLetizia Maria Ippolita Jannello, Andrea Baudo, Lukas Scheipner, et al.
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Pageof 7